Regional Oncology Strategy Director

Taiho Oncology; Princeton (NJ); On-site; USD 218,000 - 256,000; Full time

Job summary

Taiho Oncology in the United States seeks a Director, Regional Therapeutic Strategy to lead region-specific therapeutic-area strategy, translate national plans into local actions, and collaborate across Marketing, Sales, Medical Affairs, Market Access, and regional stakeholders.

You will build relationships with KOLs and academic centers, identify barriers to patient access, and drive launch readiness and lifecycle initiatives, leveraging AI and analytics while ensuring compliant,

Qualifications

• Bachelor's degree required.
• 10+ years pharmaceutical, biotechnology, or oncology industry experience.
• Significant experience in oncology marketing, sales leadership, market access, or commercial strategy.
• Demonstrated success influencing cross-functional teams without direct authority.
• Experience developing and implementing strategic business plans.

Responsibilities

• Develop and execute regional therapeutic-area strategies aligned with corporate objectives.
• Analyze market dynamics, competitive activity, treatment patterns, and customer needs to identify growth opportunities.
• Translate national brand strategies into region-specific action plans.
• Serve as a strategic advisor to commercial leadership regarding opportunities, risks, and market trends.
• Partner with Sales Leadership to align field execution with brand objectives.

Skills

Oncology marketing

Sales leadership

Market access

Commercial strategy

Executive communication

Cross-functional leadership

Product launch experience

Education

Bachelor's degree

Job description

Taiho Oncology in the United States seeks a Director, Regional Therapeutic Strategy to lead region-specific therapeutic-area strategy, translate national plans into local actions, and collaborate across Marketing, Sales, Medical Affairs, Market Access, and regional stakeholders.

You will build relationships with KOLs and academic centers, identify barriers to patient access, and drive launch readiness and lifecycle initiatives, leveraging AI and analytics while ensuring compliant,